These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11231731)

  • 41. What are fairness and consistency in a national pharmacy benefit?
    Daniels N; Sabin JE
    Med Care; 2001 Apr; 39(4):312-4. PubMed ID: 11329518
    [No Abstract]   [Full Text] [Related]  

  • 42. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Medicare Modernization Act of 2003, part D.
    Simonson W
    J Am Med Dir Assoc; 2005; 6(3):231-2. PubMed ID: 15894257
    [No Abstract]   [Full Text] [Related]  

  • 44. MMA reviews prescription drug plans.
    Minn Med; 2000 Jan; 83(1):35-6. PubMed ID: 10680430
    [No Abstract]   [Full Text] [Related]  

  • 45. Bitter pills.
    Carpenter D
    Hosp Health Netw; 2000 Aug; 74(8):48-52. PubMed ID: 10983224
    [No Abstract]   [Full Text] [Related]  

  • 46. Medicare part D prescription drug benefit--part 1 of 2.
    Klein CA
    Nurse Pract; 2006 Feb; 31(2):61. PubMed ID: 16452904
    [No Abstract]   [Full Text] [Related]  

  • 47. The first months of the prescription-drug benefit--a CMS update.
    Bach PB; McClellan MB
    N Engl J Med; 2006 Jun; 354(22):2312-4. PubMed ID: 16738266
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacy utilization and the Medicare Modernization Act.
    Maio V; Pizzi L; Roumm AR; Clarke J; Goldfarb NI; Nash DB; Chess D
    Milbank Q; 2005; 83(1):101-30. PubMed ID: 15787955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.
    Maclure M
    Milbank Q; 2005; 83(1):131-47. PubMed ID: 15787956
    [No Abstract]   [Full Text] [Related]  

  • 50. What will the new medicare drug benefit mean for Minnesota physicians?
    Liebow M
    Minn Med; 2005 Mar; 88(3):38-41. PubMed ID: 15852596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Learning the rules. Docs, others prepare for drug card questions.
    Tieman J
    Mod Healthc; 2004 Apr; 34(17):14-5. PubMed ID: 15146595
    [No Abstract]   [Full Text] [Related]  

  • 53. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medicare program; outpatient prescription drugs: list of covered home i.v. drugs--HCFA. Proposed notice.
    Fed Regist; 1989 Sep; 54(172):37239-48. PubMed ID: 10303829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Savings from Canadian Internet pharmacies are limited.
    Rothberg M
    Ann Intern Med; 2006 Feb; 144(3):224; author reply 224-5. PubMed ID: 16461977
    [No Abstract]   [Full Text] [Related]  

  • 56. View from the Nation's Capital. Prescription drug benefits under Medicare: potential effects on physician prescribing practices.
    Appler WD; McMann GL
    J Clin Psychopharmacol; 1989 Jun; 9(3):213-5. PubMed ID: 2661608
    [No Abstract]   [Full Text] [Related]  

  • 57. Medicare coverage of prescription drugs.
    Division of Advocacy and Health Policy
    Bull Am Coll Surg; 2005 Sep; 90(9):29-30, 62. PubMed ID: 18435099
    [No Abstract]   [Full Text] [Related]  

  • 58. The other drug war. Administration, HMOs playing hardball over prescription medicine benefit.
    Hallam K
    Mod Healthc; 1999 Oct; 29(40):44. PubMed ID: 10621454
    [No Abstract]   [Full Text] [Related]  

  • 59. The road all-too-well traveled: a year of Medicare Part D and what we have learned so far.
    Hays R; Paykin C
    Prog Transplant; 2007 Mar; 17(1):68-9. PubMed ID: 17484249
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.